Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.
2.

Health economic burden of patients with restless legs syndrome in a German ambulatory setting.

Dodel R, Happe S, Peglau I, Mayer G, Wasem J, Reese JP, Giani G, Geraedts M, Trenkwalder C, Oertel WH, Stiasny-Kolster K.

Pharmacoeconomics. 2010;28(5):381-93. doi: 10.2165/11531030-000000000-00000.

PMID:
20297866
3.

Restless legs syndrome: a review of diagnosis and management in primary care.

Bogan RK, Cheray JA.

Postgrad Med. 2013 May;125(3):99-111. doi: 10.3810/pgm.2013.05.2636. Review.

PMID:
23748511
4.

Recognition, diagnosis, and treatment of restless legs syndrome.

Smith JE, Tolson JM.

J Am Acad Nurse Pract. 2008 Aug;20(8):396-401. doi: 10.1111/j.1745-7599.2008.00337.x. Review.

PMID:
18786013
5.

Economic and human costs of restless legs syndrome.

Reinhold T, Müller-Riemenschneider F, Willich SN, Brüggenjürgen B.

Pharmacoeconomics. 2009;27(4):267-79. doi: 10.2165/00019053-200927040-00001. Review.

PMID:
19485424
6.

The real burden of restless legs syndrome: clinical and economic outcomes.

Salas RE, Kwan AB.

Am J Manag Care. 2012 Oct;18(9 Suppl):S207-12.

7.

Patterns of treatment for restless legs syndrome in primary care in the United Kingdom.

Martinez C, Finnern HW, Rietbrock S, Eaton S, Chaudhuri KR, Schapira AH.

Clin Ther. 2008 Feb;30(2):405-18. doi: 10.1016/j.clinthera.2008.02.001.

PMID:
18343278
8.

Prevalence and disease burden of primary restless legs syndrome: results of a general population survey in the United States.

Allen RP, Bharmal M, Calloway M.

Mov Disord. 2011 Jan;26(1):114-20. doi: 10.1002/mds.23430. Epub 2010 Nov 10.

PMID:
21322022
9.
10.
11.

Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute.

García-Borreguero D, Allen RP, Kohnen R, Högl B, Trenkwalder C, Oertel W, Hening WA, Paulus W, Rye D, Walters A, Winkelmann J, Earley CJ; International Restless Legs Syndrome Study Group.

Sleep Med. 2007 Aug;8(5):520-30. Epub 2007 Jun 1. Erratum in: Sleep Med. 2007 Nov;8(7-8):788. Earley, Christopher J [added].

PMID:
17544323
12.

Psychiatric comorbidity in children and adolescents with restless legs syndrome: a retrospective study.

Pullen SJ, Wall CA, Angstman ER, Munitz GE, Kotagal S.

J Clin Sleep Med. 2011 Dec 15;7(6):587-96. doi: 10.5664/jcsm.1456.

13.

Treatment wish of individuals with known and unknown restless legs syndrome in the community.

Happe S, Vennemann M, Evers S, Berger K.

J Neurol. 2008 Sep;255(9):1365-71. doi: 10.1007/s00415-008-0922-7. Epub 2008 Jun 27.

PMID:
18575924
14.

The Humanistic and Economic Burden of Restless Legs Syndrome.

Durgin T, Witt EA, Fishman J.

PLoS One. 2015 Oct 26;10(10):e0140632. doi: 10.1371/journal.pone.0140632. eCollection 2015. Erratum in: PLoS One. 2015;10(12):e0145139.

15.

Restless legs syndrome: detection and management in primary care. National Heart, Lung, and Blood Institute Working Group on Restless Legs Syndrome.

[No authors listed]

Am Fam Physician. 2000 Jul 1;62(1):108-14. Review. Erratum in: Am Fam Physician 2000 Aug 15;62(4):736.

16.

Sequential compression devices for treatment of restless legs syndrome.

Eliasson AH, Lettieri CJ.

Medicine (Baltimore). 2007 Nov;86(6):317-23. Review.

17.

Restless legs syndrome: clinical experience with long-term treatment.

Clavadetscher SC, Gugger M, Bassetti CL.

Sleep Med. 2004 Sep;5(5):495-500.

PMID:
15341896
18.
19.

The frequency and impact of restless legs syndrome in primary care.

O'Keeffe ST, Egan D, Myers A, Redmond S.

Ir Med J. 2007 Jul-Aug;100(7):539-42.

PMID:
17886530
20.

Treatment of idiopathic restless legs syndrome (RLS) with the D2-agonist cabergoline--an open clinical trial.

Stiasny K, Röbbecke J, Schüler P, Oertel WH.

Sleep. 2000 May 1;23(3):349-54.

PMID:
10811379
Items per page

Supplemental Content

Write to the Help Desk